Medication Abortion Is Back Before the Supreme Court, and the Stakes Are National

The mifepristone case that has landed on the Supreme Court’s shadow docket is the new face of conservative efforts to impose a nationwide ban on abortion. It’s possible that the Court is close and needs a little more time to reach a decision.

Medication Abortion Is Back Before the Supreme Court, and the Stakes Are National

The mifepristone case that has landed on the Supreme Court’s shadow docket is the new face of conservative efforts to impose a nationwide ban on abortion.

It’s possible that the Court is close and needs a little more time to reach a decision. There has been some thought it might set the case for argument on the merits as early as next month, or more realistically, next term, and decide it on the merits quickly, at least as courts count time.

But given the political weight of the issue in a midterm election year, the Court could also return to its history with mifepristone: kicking the can down the road. That’s what they did when the Texas case, Alliance for Hippocratic Medicine v. FDA, came before it in June 2024, deciding that the plaintiffs lacked standing and dismissing the case, instead of ruling on the substantive issue.

The post Medication Abortion Is Back Before the Supreme Court, and the Stakes Are National appeared first on Ms. Magazine.

Need Support?

Find verified resources for reproductive healthcare, support services, and advocacy organizations.

Find Resources